Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mauricio Castillo-Salazar"'
Autor:
Luis M Amezcua-Guerra, Leonardo del Valle, Héctor González-Pacheco, Rashidi Springall, Ricardo Márquez-Velasco, Felipe Massó, Malinalli Brianza-Padilla, Daniel Manzur-Sandoval, Julieta González-Flores, Carlos García-Ávila, Yaneli Juárez-Vicuña, Fausto Sánchez-Muñoz, Martha A Ballinas-Verdugo, Edna Basilio-Gálvez, Araceli Paez-Arenas, Mauricio Castillo-Salazar, Sergio Cásares-Alvarado, Adrián Hernández-Diazcouder, José L Sánchez-Gloria, Claudia Tavera-Alonso, Rodrigo Gopar-Nieto, Julio Sandoval
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 16 (2022)
Background: Information about angiotensin II (Ang II), angiotensin-converting enzyme 2 (ACE2), and Ang-(1–7) levels in patients with COVID-19 is scarce. Objective: To characterize the Ang II–ACE2–Ang-(1–7) axis in patients with SARS-CoV-2 inf
Externí odkaz:
https://doaj.org/article/78c43c6947294aaaae6435b9fae4f8ef
Autor:
Mauricio Castillo-Salazar, Fausto Sánchez-Muñoz, Rashidi Springall del Villar, Gabriel Navarrete-Vázquez, Adrián Hernández-DiazCouder, Carlos Mojica-Cardoso, Sara García-Jiménez, Cairo Toledano-Jaimes, Germán Bernal-Fernández
Publikováno v:
Biomolecules, Vol 11, Iss 12, p 1817 (2021)
Background: Type 2 diabetes (T2D) is a low-grade inflammatory condition with abnormalities in the immune response mediated by T lymphocytes and macrophages. Drug repositioning for immunomodulatory molecules is an attractive proposal for treating T2D.
Externí odkaz:
https://doaj.org/article/5b844a0bdf2f41389e68389d7f9aaa9e
Autor:
null Luis M Amezcua-Guerra, null Leonardo del Valle, null Héctor González-Pacheco, null Rashidi Springall, null Ricardo Márquez-Velasco, null Felipe Massó, null Malinalli Brianza-Padilla, null Daniel Manzur-Sandoval, null Julieta González-Flores, null Carlos García-Ávila, null Yaneli Juárez-Vicuña, null Fausto Sánchez-Muñoz, null Martha A Ballinas-Verdugo, null Edna Basilio-Gálvez, null Araceli Paez-Arenas, null Mauricio Castillo-Salazar, null Sergio Cásares-Alvarado, null Adrián Hernández-Diazcouder, null José L Sánchez-Gloria, null Claudia Tavera-Alonso, null Rodrigo Gopar-Nieto, null Julio Sandoval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec11c487615ec139fb7757092349a91
https://doi.org/10.1177/17534666221122544/v3/response1
https://doi.org/10.1177/17534666221122544/v3/response1
Autor:
Rashidi Springall, Julieta González-Flores, Carlos García-Ávila, Yaneli Juárez-Vicuña, Adrián Hernández-Diazcouder, Ricardo Márquez-Velasco, Sergio Cásares-Alvarado, Fausto Sánchez-Muñoz, Edna Basilio-Gálvez, Mauricio Castillo-Salazar, Martha A. Ballinas-Verdugo, Malinalli Brianza-Padilla, José L. Sánchez-Gloria, Claudia Tavera-Alonso, Julio Sandoval, Héctor González-Pacheco, Luis M. Amezcua-Guerra
Publikováno v:
Archivum immunologiae et therapiae experimentalis. 70(1)
To evaluate soluble CD147 levels in COVID-19 and identify whether these are associated with hyperinflammation and disease severity. One-hundred and nine COVID-19 patients and 72 healthy blood donors were studied. Levels of CD147, matrix metalloprotea
Autor:
Yaneli Juárez-Vicuña, Edna Basilio-Gálvez, Martha A Ballinas-Verdugo, Claudia Tavera-Alonso, Francisco M. Baranda-Tovar, Mauricio Castillo-Salazar, Rashidi Springall, Héctor González-Pacheco, Carlos García-Ávila, Ricardo Márquez-Velasco, Fausto Sánchez-Muñoz, Julieta González-Flores, Malinalli Brianza-Padilla, Gustavo Rojas-Velasco, Julio Sandoval, José L. Sánchez-Gloria, Sergio Cásarez-Alvarado, Adrián Hernández-Díazcouder, Luis M. Amezcua-Guerra
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3657, p 3657 (2021)
Journal of Clinical Medicine
Volume 10
Issue 16
Journal of Clinical Medicine
Volume 10
Issue 16
Background: Several easy-to-use risk scoring systems have been built to identify patients at risk of developing complications associated with COVID-19. However, information about the ability of each score to early predict major adverse outcomes durin